GO:0035851 Krueppel-associated box domain binding

GO:0035851, Krueppel-associated box domain binding, is a molecular function that captures the physical and functional interaction between a protein and a Krueppel-associated box (KRAB) domain. The KRAB domain is an approximately 75-amino-acid module enriched in charged amino acids and is located in the N-terminal region of many zinc finger-containing transcription factors. Proteins that bind this domain are often transcriptional corepressors that convert DNA-binding zinc finger factors into potent silencers of gene expression. Because KRAB-domain binding is a central node in transcriptional repression, it is a recurring target in studies of gene regulation, synthetic biology, and cancer [1,3]. The functional importance of GO:0035851 extends from basic chromatin biology to applied genome engineering. Synthetic trigger-controlled bipartite transcription factors have been built by exploiting KRAB-domain interactions, demonstrating that this binding event can be repurposed to control mammalian gene expression. In cancer research, programmable and targeted de novo DNA methylation using KRAB-domain-containing factors has been shown to achieve stable oncogenic silencing in vivo in breast cancer models. These examples show that GO:0035851 is not merely a descriptive annotation but a mechanistic handle for manipulating gene expression. Researchers studying GO:0035851 need to know which proteins bind KRAB domains, how binding is regulated, and what downstream genes are silenced. This article synthesizes the QuickGO definition with verified PubMed literature to provide a research-grade overview of the term, its associated genes, disease links, and the CRISPR-based methods used to interrogate it [1,2,3,4].

GO:0035851 is defined by QuickGO as binding to a Krueppel-associated box (KRAB) domain of a protein. The KRAB domain is approximately 75 amino acids long, is enriched in charged amino acids, and is found in the N-terminal regions of many zinc finger-containing transcription factors. In practice, this molecular function describes the selective recognition of the KRAB domain by a binding partner, which typically leads to assembly of a transcriptional repression complex.

GO:0035851 is important because KRAB-domain binding is the molecular switch that converts many zinc finger transcription factors into repressors. This function underlies normal developmental gene regulation and is hijacked or dysregulated in disease, including cancer [1,3]. It is also a design principle in synthetic biology, where engineered bipartite transcription factors use KRAB-domain interactions to achieve trigger-controlled gene regulation. Understanding this term therefore connects basic transcription factor biology to therapeutic strategies such as targeted epigenetic silencing.

The following genes and proteins are directly or contextually linked to KRAB-domain binding and its downstream repression functions in the verified literature.

KRAB-domain binding is regulated at multiple levels. In synthetic systems, trigger-controlled bipartite transcription factors make the binding event conditional on a small-molecule input, allowing temporal control of repression. In natural contexts, the availability of corepressors and the chromatin state of target loci influence whether KRAB-domain binding leads to stable silencing [1,3]. The interaction between viral and cellular proteins, as seen with RTA (ORF50), further shows that KRAB-related interactions can be modulated by context-specific cofactors.

KRAB-domain binding is directly relevant to cancer because it enables stable silencing of oncogenes. Programmable and targeted de novo DNA methylation using KRAB-domain-containing factors has been shown to achieve stable oncogenic silencing in vivo in breast cancer models. This establishes GO:0035851 as a mechanistic entry point for epigenetic cancer therapy.

The transcription factor ZNF25, which is associated with osteoblast differentiation of human skeletal stem cells, highlights a role for KRAB-domain-containing zinc finger proteins in bone biology. Dysregulation of such factors could contribute to skeletal disorders, although direct disease mechanisms require further study.

Kaposi's sarcoma-associated herpesvirus RTA (ORF50) interacts with a cellular protein that synergizes in transcriptional activation, illustrating how viral proteins can interface with KRAB-related cellular machinery. This context is important for understanding how viral infections may perturb host repression networks.

RNA-seq is used to identify genes de-repressed upon loss of KRAB-domain binding or silenced upon its activation. In breast cancer models, targeted de novo DNA methylation produces stable changes in gene expression that can be measured by transcriptomics. This method is essential for linking GO:0035851 to downstream biology.

Affinity purification and mass spectrometry can identify proteins that bind the KRAB domain. Such approaches complement genetic studies by defining the composition of repression complexes. The interaction between RTA (ORF50) and cellular proteins illustrates the value of proteomic mapping for context-dependent interactions.

DNA methylation and chromatin accessibility assays measure the epigenetic consequences of KRAB-domain binding. These readouts are particularly important for demonstrating stable silencing, as shown in breast cancer models. They distinguish transient repression from durable epigenetic changes.

Reporter genes and trigger-controlled bipartite transcription factors provide quantitative measures of KRAB-domain-dependent repression. These systems allow dose-response and time-course experiments that are difficult in native contexts.

Researchers studying Krueppel-associated box domain binding-related genes often need to determine whether a candidate gene is causally involved in repression, differentiation, or disease. EDITGENE provides the CRISPR cell models and screening services required to move from correlation to causation.

GO:0035851, Krueppel-associated box domain binding, is a molecular function that connects zinc finger transcription factors to corepressor complexes and stable gene silencing. Its roles span normal differentiation, cancer epigenetics, and synthetic gene circuits [1,2,3]. Understanding this term provides a framework for interrogating repression mechanisms with CRISPR-based models and multi-omics readouts [1,3]. As the literature on KRAB-domain proteins expands, GO:0035851 will remain a key annotation for linking genotype to transcriptional repression. Researchers can leverage EDITGENE services to build the knockout, point-mutation, knock-in, overexpression, and screening models needed to test causal roles of KRAB-domain binding in health and disease [1,2,3].